ReposiTrak Delivers Earnings Per Share of $0.08, Grows Recurring Revenue 6% in Fiscal Third Quarter

Rhea-AI Summary

ReposiTrak (NYSE: TRAK) reported fiscal Q3 2024 results, showing a 5% increase in total revenue to $5.1 million and a 6% rise in recurring revenue. Despite a 15% increase in operating expenses, the company maintained an EPS of $0.08. GAAP net income decreased by 7% to $1.6 million. ReposiTrak ended the quarter with $24.5 million in cash and no debt. The company redeemed 70,093 preferred shares for $749,995 and plans to redeem all preferred shares over three years. CEO Randall K. Fields noted significant growth in the ReposiTrak Traceability Network, predicting a doubling of revenue over the next three years.

Positive

• Total revenue increased by 5% to $5.1 million.
• Recurring revenue rose by 6%, representing 99% of total revenue.
• Maintained EPS of $0.08, unchanged from the prior year.
• Ended the quarter with $24.5 million in cash and no debt.
• Redeemed 70,093 preferred shares for $749,995.
• Predicted doubling of revenue from traceability over the next three years.

Negative

• Operating expenses increased by 15%.
• GAAP net income decreased by 7% to $1.6 million.
• Net income to common shareholders decreased by 7%.
• Operating income decreased by 17%.

Insights

Financial Analyst

ReposiTrak's performance in the third fiscal quarter provides valuable insights into the company's financial health and strategic direction. The company's 5% revenue growth to $5.1 million and a 6% increase in recurring revenue indicate sustained customer retention and potential expansion in their market. However, the 15% rise in operating expenses, primarily driven by an increase in general and administrative expenses, presents a red flag. It's important to note that the prior year's performance was bolstered by a non-recurring Employee Retention Credit (ERC) of ~$1 million. Without this credit, the company's operating income would have increased by approximately $800,000.

For investors, the fact that quarterly GAAP net income decreased by 7% to $1.6 million may be concerning, but excluding the non-recurring credit, net income showed a substantial increase. This context is essential for understanding the underlying performance improvements. Also noteworthy is the quarterly EPS remaining unchanged at $0.08, which shows stable profitability levels.

The company's cash position is strong with $24.5 million and no debt, providing a cushion for future investments and shareholder returns. The redemption of preferred shares and a 10% increase in cash dividends highlight management's commitment to returning capital to shareholders, which can be seen positively for income-focused investors.

Market Research Analyst

ReposiTrak's focus on the traceability and regulatory compliance sectors aligns well with current industry trends. The ongoing onboarding of new traceability customers and the expectation that traceability revenue could double over the next three years reflects significant market opportunities. The fact that traceability revenue now represents approximately 5% of their consolidated revenue is a sign of early but promising traction.

The FSMA 204 deadline is expected to drive more companies towards compliance solutions, positioning ReposiTrak advantageously. Their statement on already exceeding initial market size estimates and the forecasted jump in annual recurring revenue (ARR) underscore the potential for sustained growth in this niche. However, it's important for investors to monitor how these projections translate into actual financial performance and how competitive pressures may impact their market share.

The redemption of preferred shares and buyback programs might indicate a strong cash flow position, but they also reduce the cash available for reinvestment in growth opportunities. Investors should weigh the benefits of immediate shareholder returns against the potential for long-term growth investments.

Onboarding of Traceability Customers Continues to Accelerate; Company Ends Quarter with $24.5 Million in Cash, No Debt

SALT LAKE CITY--(BUSINESS WIRE)-- ReposiTrak (NYSE: TRAK), the world's largest food traceability and regulatory compliance network, built upon its proven inventory management and out-of-stock reduction SaaS platform, today announced financial results for the third fiscal quarter (“FQ3 2024”) ended March 31, 2024.

Third Quarter Financial Highlights:

• Third quarter total revenue increased 5% to $5.1 million from $4.8 million.
• Recurring revenue increased 6%, net of the planned elimination of high-touch, low-opportunity revenue, to $5.1 million from $4.8 million, representing approximately 99% of total revenue.
• Quarterly operating expense increased 15% to $3.8 million from $3.3 million. The third fiscal quarter last year included approximately $1 million in an Employee Retention Credit (“ERC”), reducing general and administrative expenses.
• Quarterly operating income decreased 17% to $1.3 million from $1.5 million last year. Excluding the non-recurring ERC credit in the third fiscal quarter last year, operating income would have increased approximately $800,000 year-over-year.
• Quarterly GAAP net income decreased 7% to $1.6 million from $1.7 million last year. Excluding the non-recurring ERC credit in the third fiscal quarter last year, net income would have increased approximately $900,000 year-over-year.
• Quarterly net income to common shareholders was $1.4 million, down 7% from $1.5 million last year. Excluding the non-recurring ERC credit in the third fiscal quarter last year, net income to common shareholders would have increased approximately $900,000 year-over-year.
• Quarterly EPS of $0.08, unchanged from the prior year.
• During the quarter, the Company redeemed 70,093 preferred shares for the stated redemption price of $10.70 per share for a total of $749,995.
• The Company finished the quarter with $24.5 million in cash and no bank debt.

Randall K. Fields, Chairman and CEO of ReposiTrak, commented, “We continue to add new retailers and suppliers to the ReposiTrak Traceability Network. Revenue from traceability now represents approximately 5% of our consolidated revenue, on an annualized basis, and we are more confident than ever that Traceability will double our revenue over the next three years. The production facilities in hand that have been already been implemented, and those in the queue to be implemented in the ReposiTrak Traceability Network (RTN), already exceed our initial estimates for the market size and represents an annual recurring revenue (ARR) that is expected to double our revenue base over the next three years.”

“Meanwhile, we continue to maintain robust profitability, returning capital to shareholders in the form of a cash dividend, redeeming preferred shares, all while growing our cash balances,” added Fields. “This approach will not change. ReposiTrak is the clear leader in the rapidly unfolding traceability industry, as evidenced by our market share, industry endorsements, and the near-term investments are already beginning to lead to higher revenue, earnings, and cash as the FSMA 204 deadline is right around the corner.”

Third Fiscal Quarter Financial Results (three months ended March 31, 2024, vs. three months ended March 31, 2023):

Total revenue was up 5% to $5.08 million as compared to $4.82 million in the prior-year third quarter. Total operating expenses were $3.82 million, up 15% compared to $3.30 million last year. General and administrative expenses increased by 48%. GAAP net income was $1.55 million compared to $1.66 million. Net income to common shareholders was $1.42 million, or $0.08 per diluted share, compared to $1.52 million, or $0.08 per diluted share.

Year-to-Date Financial Results (nine months ended March 31, 2024, vs. nine months ended March 31, 2023):

Total revenue was up 7% to $15.27 million as compared to $14.30 million in the prior-year period. Total operating expense was $11.57 million, up 12% compared to $10.37 million last year. The third fiscal quarter last year included non-recurring Employee Retention Credit benefit of approximately $1 million, reducing the year-ago operating expense. Inclusive of the impact of this credit in the year-ago quarter, GAAP net income was $4.38 million compared to $4.21 million. Net income to common shareholders was $3.95 million, or $0.22 per basic and $0.21 per diluted share, compared to $3.77 million, or $0.20 per basic and $0.20 per diluted share last year.

Return of Capital:

In the third quarter of fiscal 2024, the Company redeemed another 70,093 preferred shares at the stated redemption price of $10.70 per share for a total of $749,995. The remaining amount of the preferred share redemption is $7.46 million. As previously announced, the Company anticipates redeeming all of its preferred shares issued and outstanding over the next three years. In addition, the Company has approximately $8 million remaining on the $21 million total common share buyback authorization.

In September 2022, the Company’s Board of Directors declared a quarterly cash dividend of $0.015 per share ($0.06 per year). In November 2023, the Board of Directors approved a 10% increase in the quarterly cash dividend, to 6.6 cents per share annually, or 1.65 cents per share quarterly, commencing with the December 2023 dividend.

Balance Sheet:

The Company had $24.5 million in cash and cash equivalents at March 31, 2024, compared to $24.0 million at June 30, 2023. The Company had nothing drawn on its working line of credit as of March 31, 2024 or June 30, 2023.

Conference Call:

The Company will host a conference call at 4:15 p.m. Eastern today to discuss the Company’s results. The conference call will also be webcast and will be available via the investor relations section of the Company’s website, www.parkcitygroup.com.

Participant Dial-In Numbers:
Date: Wednesday, May 15, 2024
Time: 4:15 p.m. ET (1:15 p.m. PT)
Toll-Free: 1-877-300-8521
Toll/International 1-412-317-6026
Conference ID: 10188893

Replay Dial-In Numbers:
Toll Free: 1-844-512-2921
Toll/International: 1-412-317-6671
Replay Start: Wednesday, May 15, 2024, 7:15 p.m. ET
Replay Expiry: Saturday, June 15, 2024, at 11:59 PM ET
Replay Pin Number: 10188893

About ReposiTrak

ReposiTrak (NYSE:TRAK), formerly Park City Group, provides retailers, suppliers and wholesalers with a robust solution suite to help reduce risk and remain in compliance with regulatory requirements, enhance operational controls and increase sales with unrivaled brand protection. Consisting of three product families – food traceability, compliance and risk management and supply chain solutions – ReposiTrak’s integrated, cloud-based applications are supported by an unparalleled team of experts. For more information, visit https://repositrak.com

Forward-Looking Statement

Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “may,” “plan,” “project,” “predict,” “if”, “should” and “will” and similar expressions as they relate to Park City Group, Inc., Park City Group d/b/a ReposiTrak, or ReposiTrak (“Park City Group”) are intended to identify such forward-looking statements. Park City Group may from time-to-time update these publicly announced projections, but it is not obligated to do so. Any projections of future results of operations should not be construed in any manner as a guarantee that such results will in fact occur. These projections are subject to change and could differ materially from final reported results. For a discussion of such risks and uncertainties, see “Risk Factors” in Park City Group annual report on Form 10-K, its quarterly report on Form 10-Q, and its other reports filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.

REPOSITRAK, INC. Consolidated Condensed Balance Sheets (Unaudited)
		March 31, 2024				June 30, 2023
Assets
Current Assets
Cash and cash equivalents		$	24,452,680			$	23,990,879
Receivables, net of allowance for doubtful accounts of $226,198 and $170,103 at March 31, 2024 and June 30, 2023, respectively			3,776,472				2,523,019
Contract asset – unbilled current portion			147,520				186,959
Prepaid expense and other current assets			451,041				573,763
Total Current Assets			28,827,713				27,274,620
Property and Equipment, net			591,724				986,300
Other Assets:
Deposits and other assets			22,414				22,414
Prepaid expense – less current portion			6,677				36,282
Contract asset – unbilled long-term portion			108,052				108,052
Operating lease – right-of-use asset			265,726				310,796
Customer relationships			164,250				262,800
Goodwill			20,883,886				20,883,886
Capitalized software costs, net			463,036				698,281
Total Other Assets			21,914,041				22,322,511
Total Assets		$	51,333,478			$	50,583,431
Liabilities and Shareholders’ Equity
Current Liabilities
Accounts payable		$	510,412			$	431,387
Accrued liabilities			1,390,232				1,620,000
Contract liability – deferred revenue			2,466,262				1,903,001
Operating lease liability – current			62,725				58,771
Notes payable and financing leases – current			215,274				219,262
Total Current Liabilities			4,644,905				4,232,421
Long-Term Liabilities
Operating lease liability – less current portion			215,676				263,047
Notes payable and financing leases – less current portion			-				206,032
Total Liabilities			4,860,581				4,701,500
Commitments and Contingencies
Stockholders’ Equity:
Preferred Stock; $0.01 par value, 30,000,000 shares authorized;
Series B Preferred, 700,000 shares authorized; 625,375 shares issued and outstanding at March 31, 2024 and June 30, 2023;			6,254				6,254
Series B-1 Preferred, 550,000 shares authorized; 72,216 and 212,402 shares issued and outstanding at March 31, 2024 and June 30, 2023, respectively			722				2,124
Common Stock, $0.01 par value, 50,000,000 shares authorized; 18,221,527 and 18,309,051 issued and outstanding at March 31, 2024 and June 30, 2023, respectively			182,218				183,093
Additional paid-in capital			65,277,419				67,732,887
Accumulated other comprehensive loss			(31,006	)			-
Accumulated deficit			(18,962,710	)			(22,042,427	)
Total Stockholders’ Equity			46,472,897				45,881,931
Total Liabilities and Stockholders’ Equity		$	51,333,478			$	50,583,431

REPOSITRAK, INC. Consolidated Condensed Statements of Operations and Comprehensive Income (Unaudited)
		Three Months Ended March 31,								Nine Months Ended March 31,
		2024				2023				2024				2023
Revenue		$	5,084,866			$	4,824,101			$	15,270,729			$	14,295,091
Operating expense:
Cost of services and product support			831,912				840,272				2,571,533				2,539,618
Sales and marketing			1,349,838				1,239,946				4,119,716				3,667,017
General and administrative			1,352,197				916,237				3,978,798				3,392,056
Depreciation and amortization			288,576				305,864				897,479				771,030
Total operating expense			3,822,523				3,302,319				11,567,526				10,369,721
Income from operations			1,262,343				1,521,782				3,703,203				3,925,370
Other income (expense):
Interest income			350,691				275,941				925,297				554,299
Interest expense			(8,036	)			(9,771	)			(21,956	)			(52,481	)
Unrealized gain (loss) on short term investments			5,429				35,068				48,071				(3,753	)
Other gain			-				-				-				70,047
Income before income taxes			1,610,427				1,823,020				4,654,615				4,493,482
(Provision) for income taxes:			(60,000	)			(160,000	)			(274,491	)			(280,006	)
Net income			1,550,427				1,663,020				4,380,124				4,213,476
Dividends on preferred stock			(134,345	)			(146,611	)			(427,567	)			(439,833	)
Net income applicable to common shareholders		$	1,416,082			$	1,516,409			$	3,952,557			$	3,773,643
Weighted average shares, basic			18,194,000				18,394,000				18,194,000				18,408,000
Weighted average shares, diluted			18,954,000				18,751,000				18,874,000				18,702,000
Basic income per share		$	0.08			$	0.08			$	0.22			$	0.20
Diluted income per share		$	0.08			$	0.08			$	0.21			$	0.20

REPOSITRAK, INC. Consolidated Condensed Statements of Cash Flows (Unaudited)
		Nine months Ended March 31,
		2024				2023
Cash flows from operating activities:
Net income		$	4,380,124			$	4,213,476
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization			897,479				771,030
Amortization of operating right-of-use asset			45,070				43,019
Stock compensation expense			260,853				315,216
Bad debt expense			225,000				1,200,000
(Increase) decrease in:
Accounts receivables			(1,439,014	)			86,972
Long-term receivables, prepaids and other assets			751				655,391
Increase (decrease) in:
Accounts payable			79,025				(309,812	)
Operating lease liability			(43,417	)			(39,777	)
Accrued liabilities			(58,391	)			122,744
Deferred revenue			563,261				7,631
Net cash provided by operating activities			4,910,741				7,065,890
Cash flows from investing activities:
Purchase of property and equipment			(17,532	)			(133,944	)
Capitalization of software costs			-				(769,243	)
Purchase of marketable securities			(31,006	)			-
Net cash (used in) investing activities			(48,538	)			(903,187	)
Cash flows from financing activities:
Net (decrease) in lines of credit			-				(2,590,907	)
Common Stock buyback/retirement			(1,515,574	)			(981,194	)
Redemption of series B-1 preferred			(1,499,990	)			-
Proceeds from employee stock plan			111,839				92,728
Dividends paid			(1,286,657	)			(993,037	)
Payments on notes payable and capital leases			(210,020	)			(209,748	)
Net cash used in financing activities			(4,400,402	)			(4,682,158	)
Net increase (decrease) in cash and cash equivalents			461,801				1,480,545
Cash and cash equivalents at beginning of period			23,990,879				21,460,948
Cash and cash equivalents at end of period		$	24,452,680			$	22,941,493
Supplemental disclosure of cash flow information:
Cash paid for income taxes		$	317,944			$	264,486
Cash paid for interest		$	11,711			$	52,481
Cash paid for operating leases		$	54,606			$	53,015
Supplemental disclosure of non-cash investing and financing activities:
Common stock to pay accrued liabilities		$	445,980			$	256,977
Dividends accrued on preferred stock		$	427,567			$	439,833

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20240515114345/en/

Investor Relations Contact:

John Merrill, CFO

Investor-relations@repositrak.com

Or

FNK IR

Rob Fink

646.809.4048

rob@fnkir.com

Source: ReposiTrak

FAQ

What were ReposiTrak's Q3 2024 earnings per share (EPS)?

ReposiTrak reported Q3 2024 earnings per share (EPS) of $0.08.

How much did ReposiTrak's total revenue increase in Q3 2024?

ReposiTrak's total revenue increased by 5% to $5.1 million in Q3 2024.

What was ReposiTrak's recurring revenue growth in Q3 2024?

ReposiTrak's recurring revenue grew by 6% in Q3 2024.

How much cash did ReposiTrak have at the end of Q3 2024?

ReposiTrak had $24.5 million in cash at the end of Q3 2024.

What was the increase in ReposiTrak's operating expenses in Q3 2024?

ReposiTrak's operating expenses increased by 15% in Q3 2024.

How did ReposiTrak's GAAP net income change in Q3 2024?

ReposiTrak's GAAP net income decreased by 7% to $1.6 million in Q3 2024.

What is ReposiTrak's forecast for traceability revenue growth?

ReposiTrak forecasts that traceability revenue will double over the next three years.

What was the amount spent on redeeming preferred shares by ReposiTrak in Q3 2024?

ReposiTrak spent $749,995 on redeeming preferred shares in Q3 2024.